Scientists are rapidly focused on retatrutide, a promising medication created by Eli Lilly, as a significant step in physique loss . Distinct from many previous approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, hormones that affect satiety and blood glucose regul